The Fourth Swedish National Pension Fund has sold shares in pharmaceutical company Egetis Therapeutics, thereby falling below the 5 percent disclosure threshold.
The holding decreased from 31.2 million to 17 million shares, corresponding to 3.5 percent of the shares and 3.6 percent of the votes after the transaction.
